Compounds > 4-(2-(indol-3-yl)vinyl)-1-methylpyridinium
Page last updated: 2024-11-11

4-(2-(indol-3-yl)vinyl)-1-methylpyridinium

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-(2-(indol-3-yl)vinyl)-1-methylpyridinium: a mitochondriotoxic compound that has antineoplastic activity; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6454928
MeSH IDM0446553

Synonyms (7)

Synonym
4-(2-(1h-indol-3-yl)vinyl)-1-methylpyridinium chloride
4-(2-(indol-3-yl)vinyl)-1-methylpyridinium
einecs 264-993-4
64651-39-4
f16 compound
4-[2-(1h-indol-3-yl)vinyl]-1-methylpyridinium chloride
3-[(e)-2-(1-methylpyridin-1-ium-4-yl)ethenyl]-1h-indole;chloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (40.00)29.6817
2010's5 (50.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.15 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.63 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
lactic acid
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed). 2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.		2.03102-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
tetraphenylphosphonium
tetraphenylphosphonium: RN given refers to parent cpd; structure. tetraphenylphosphonium : A polyatomic cation consisting of four phenyl groups attached to a central phosphonium.		2.110heteroorganic entity;
phosphorus molecular entity;
polyatomic cation
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene
[no description available]		2.1110BODIPY compound
ConditionIndicatedRelationship StrengthStudiesTrials
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.		02.4110
Colorectal Cancer
[description not available]		02.4110
Colorectal Neoplasms
Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.		02.4110
Breast Cancer
[description not available]		02.4620
Angiogenesis, Pathologic
[description not available]		02.1510
Breast Neoplasms
Tumors or cancer of the human BREAST.		02.4620
Experimental Neoplasms
[description not available]		02.1110
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)		02.1110
Animal Mammary Carcinoma
[description not available]		02.0110
Experimental Mammary Neoplasms
[description not available]		02.4220
Carcinoma, Anaplastic
[description not available]		02.0210
Carcinoma
A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.		02.0210
Necrosis
The death of cells in an organ or tissue due to disease, injury or failure of the blood supply.		02.0210
Cell Transformation, Neoplastic
Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.		02.0310